(Q44542563)

4 December 2017

The maternal benefits of corticosteroids with HELLP (hemolysis, elevated liver enzymes, low platelet count) syndrome (English)

1 reference

4 December 2017

Joan M G Crane

1

1 reference

PubMed ID

12908017

4 December 2017

Baharak Tabarsi

series ordinal

2

1 reference

PubMed ID

12908017

4 December 2017

Donna Hutchens

series ordinal

3

1 reference

4 December 2017

1 August 2003

1 reference

Journal of Obstetrics and Gynaecology Canada

4 December 2017

1 reference

4 December 2017

25

1 reference

4 December 2017

8

1 reference

4 December 2017

650-655

1 reference

Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a review of diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Thrombocytopenia in preeclampsia: associated abnormalities and management principles

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

1 reference

7 January 2021

Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Corticosteroids for the enhancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Corticosteroids for enhanced fetal lung maturation in patients with HELLP syndrome: impact on neonates

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

The natural history of HELLP syndrome: patterns of disease progression and regression

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP).

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Dexamethasone in the post-partum treatment of HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Effects of postpartum corticosteroids in patients with HELLP syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

Management of complicated preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2930123-2

7 January 2021

10.1016/S1701-2163(16)30123-2

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

12908017